Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure

NCT02864316 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Poor accrual

Conditions

Solid Tumors Induced by Prior Radiation Exposure

Interventions

DRUG: Nivolumab

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]